{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:05:40Z","timestamp":1792739140935,"version":"4.5.0"},"reference-count":65,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,11]]},"DOI":"10.20945\/2359-3997000000149","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T09:18:48Z","timestamp":1563959928000},"source":"Crossref","is-referenced-by-count":18,"title":["Metabolic phenotypes of obese, overweight, and normal weight individuals and risk of chronic kidney disease: a systematic review and meta-analysis"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1661-4341","authenticated-orcid":false,"given":"Shahab","family":"Alizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9526-9330","authenticated-orcid":false,"given":"Hamed","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-8743","authenticated-orcid":false,"given":"Mohammad","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1400-8532","authenticated-orcid":false,"given":"Elnaz","family":"Daneshzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-9349","authenticated-orcid":false,"given":"Loghman","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5233-5230","authenticated-orcid":false,"given":"Hossein","family":"Radfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0508-4085","authenticated-orcid":false,"given":"Mohammad Kazem","family":"Radaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"3","key":"key20190724090328_B1","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/S2214-109X(14)70002-6","article-title":"The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis","volume":"2","author":"Stanifer","year":"2014","unstructured":"1. Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174-81.","journal-title":"Lancet Glob Health"},{"issue":"9","key":"key20190724090328_B2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ejcn.2014.112","article-title":"The effects of soy protein on chronic kidney disease: a meta-analysis of randomized controlled trials","volume":"68","author":"Zhang","year":"2014","unstructured":"2. Zhang J, Liu J, Su J, Tian F. The effects of soy protein on chronic kidney disease: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2014;68(9):987-93.","journal-title":"Eur J Clin Nutr"},{"issue":"7","key":"key20190724090328_B3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","unstructured":"3. Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7):e1001680.","journal-title":"PLoS Med"},{"issue":"1","key":"key20190724090328_B4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/10799893.2014.926927","article-title":"Association of vitamin D receptor BsmI (rs1544410) gene polymorphism with the chronic kidney disease susceptibility","volume":"35","author":"Zhou","year":"2015","unstructured":"4. Zhou TB, Jiang ZP, Huang MF. Association of vitamin D receptor BsmI (rs1544410) gene polymorphism with the chronic kidney disease susceptibility. J Recept Signal Transduct Res. 2015;35(1):54-7.","journal-title":"J Recept Signal Transduct Res"},{"key":"key20190724090328_B5","first-page":"37","article-title":"Managing chronic kidney disease","volume":"8","author":"Johnson","year":"2007","unstructured":"5. Johnson DW, Mathew T. Managing chronic kidney disease. Med Today. 2007;8:37-45","journal-title":"Med Today"},{"issue":"21-22","key":"key20190724090328_B6","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.cca.2011.07.014","article-title":"Metabolic syndrome and chronic kidney disease in a rural Chinese population","volume":"412","author":"Jiang","year":"2011","unstructured":"6. Jiang L, Liang Y, Qiu B, Wang F, Duan X, Yang X, et al. Metabolic syndrome and chronic kidney disease in a rural Chinese population. Clin Chim Acta. 2011;412(21-22):1983-8.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"key20190724090328_B7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/joim.12130","article-title":"Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with chronic kidney disease","volume":"275","author":"Huang","year":"2014","unstructured":"7. Huang X, Sj\u00f6gren P, \u00c4rnl\u00f6v J, Cederholm T, Lind L, Stenvinkel P, et al. Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with chronic kidney disease. J Intern Med. 2014;275(1):71-83.","journal-title":"J Intern Med"},{"key":"key20190724090328_B8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/IJNRD.S39739","article-title":"Obesity, hypertension, and chronic kidney disease","volume":"7","author":"Hall","year":"2014","unstructured":"8. Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis. 2014;7:75-88.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"12","key":"key20190724090328_B9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.numecd.2010.02.008","article-title":"IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects","volume":"21","author":"Sesti","year":"2011","unstructured":"9. Sesti G, Succurro E, Arturi F, Andreozzi F, Laino I, Perticone M, et al. IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects. Nutr Metab Cardiovasc Dis. 2011;21(12):933-40.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"15","key":"key20190724090328_B10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)","volume":"168","author":"Wildman","year":"2008","unstructured":"10. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617-24.","journal-title":"Arch Intern Med"},{"issue":"3","key":"key20190724090328_B11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/nep.12023","article-title":"Obesity and its relation to chronic kidney disease: a population\u2010based, cross\u2010sectional study of a Thai army population and relatives","volume":"18","author":"Satirapoj","year":"2013","unstructured":"11. Satirapoj B, Supasyndh O, Mayteedol N, Punpanich D, Chaiprasert A, Nata N, et al. Obesity and its relation to chronic kidney disease: a population\u2010based, cross\u2010sectional study of a Thai army population and relatives. Nephrology (Carlton). 2013;18(3):229-34.","journal-title":"Nephrology (Carlton)"},{"key":"key20190724090328_B12","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-6-7","article-title":"Does treating obesity stabilize chronic kidney disease?","volume":"6","author":"Agnani","year":"2005","unstructured":"12. Agnani S, Vachharajani VT, Gupta R, Atray NK, Vachharajani TJ. Does treating obesity stabilize chronic kidney disease? BMC Nephrol. 2005;6:1.","journal-title":"BMC Nephrol"},{"issue":"2","key":"key20190724090328_B13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000215739","article-title":"Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals","volume":"32","author":"Ishizaka","year":"2009","unstructured":"13. Ishizaka Y, Ishizaka N, Tani M, Toda A, Toda E, Koike K, et al. Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals. Kidney Blood Press Res. 2009;32(2):141-9.","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"key20190724090328_B14","first-page":"761","article-title":"Association of obesity with inflammation in occult chronic kidney disease","volume":"21","author":"Bavbek","year":"2008","unstructured":"14. Bavbek N, Isik B, Kargili A, Uz E, Uz B, Kanbay M, et al. Association of obesity with inflammation in occult chronic kidney disease. J Nephrol. 2008;21(5):761-7.","journal-title":"J Nephrol"},{"issue":"5","key":"key20190724090328_B15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/j.ajkd.2005.08.015","article-title":"Association between body mass index and CKD in apparently healthy men","volume":"46","author":"Gelber","year":"2005","unstructured":"15. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46(5):871-80.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"key20190724090328_B16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/01.HYP.26.4.610","article-title":"Combined renal effects of overweight and hypertension","volume":"26","author":"Ribstein","year":"1995","unstructured":"16. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension. 1995;26(4):610-5.","journal-title":"Hypertension"},{"issue":"5","key":"key20190724090328_B17","doi-asserted-by":"crossref","first-page":"F817","DOI":"10.1152\/ajprenal.2000.278.5.F817","article-title":"Glomerular hemodynamics in severe obesity","volume":"278","author":"Chagnac","year":"2000","unstructured":"17. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278(5):F817-22.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"key20190724090328_B18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archinte.167.7.642","article-title":"Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity","volume":"167","author":"McLaughlin","year":"2007","unstructured":"18. McLaughlin T, Abbasi F, Lamendola C, Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med. 2007;167(7):642-8.","journal-title":"Arch Intern Med"},{"issue":"11","key":"key20190724090328_B19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/eci.12339","article-title":"Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis","volume":"44","author":"Perez\u2010Martinez","year":"2014","unstructured":"19. Perez\u2010Martinez P, Alcala\u2010Diaz JF, Delgado\u2010Lista J, Garcia\u2010Rios A, Gomez\u2010Delgado F, Marin\u2010Hinojosa C, et al. Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis. Eur J Clin Invest. 2014;44(11):1053-64.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"key20190724090328_B20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3803\/EnM.2014.29.4.427","article-title":"Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype","volume":"29","author":"Seo","year":"2014","unstructured":"20. Seo MH, Rhee EJ. Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype. Endocrinol Metab (Seoul). 2014;29(4):427-34.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"key20190724090328_B21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ijo.2014.176","article-title":"Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study","volume":"39","author":"Eshtiaghi","year":"2015","unstructured":"21. Eshtiaghi R, Keihani S, Hosseinpanah F, Barzin M, Azizi F. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study Int J Obes (Lond). 2015;39(3):514-9.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"key20190724090328_B22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12020-015-0635-5","article-title":"Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men","volume":"50","author":"Ryoo","year":"2015","unstructured":"22. Ryoo JH, Park SK, Ye S, Choi JM, Oh CM, Kim SY, et al. Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men. Endocrine. 2015;50(3):650-8.","journal-title":"Endocrine"},{"issue":"8","key":"key20190724090328_B23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.metabol.2015.03.009","article-title":"Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes","volume":"64","author":"Eckel","year":"2015","unstructured":"23. Eckel N, M\u00fchlenbruch K, Meidtner K, Boeing H, Stefan N, Schulze MB. Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes. Metabolism. 2015;64(8):862-71.","journal-title":"Metabolism"},{"key":"key20190724090328_B24","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-015-0016-5","article-title":"Obesity phenotypes in urban and rural Cameroonians: a cross-sectional study","volume":"7","author":"Mbanya","year":"2015","unstructured":"24. Mbanya VN, Echouffo-Tcheugui JB, Akhtar H, Mbanya JC, Kengne AP. Obesity phenotypes in urban and rural Cameroonians: a cross-sectional study. Diabetol Metab Syndr. 2015;7:1.","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"key20190724090328_B25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/jc.2013-2832","article-title":"Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals","volume":"99","author":"Aung","year":"2014","unstructured":"25. Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99(2):462-8.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20190724090328_B26","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2014.46","article-title":"A novel criterion for identifying metabolically obese but normal weight individuals using the product of triglycerides and glucose","volume":"5","author":"Lee","year":"2015","unstructured":"26. Lee S, Han K, Yang H, Kim H, Cho J, Kwon H, et al. A novel criterion for identifying metabolically obese but normal weight individuals using the product of triglycerides and glucose. Nutr Diabetes. 2015;5(4):e149.","journal-title":"Nutr Diabetes"},{"issue":"15","key":"key20190724090328_B27","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","unstructured":"27. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-12.","journal-title":"JAMA"},{"issue":"12","key":"key20190724090328_B28","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/dom.13458","article-title":"Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease","volume":"20","author":"Nam","year":"2018","unstructured":"28. Nam KH, Yun HR, Joo YS, Kim J, Lee S, Lee C, et al. Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease. Diabetes Obes Metab. 2018;20(12):2778-91.","journal-title":"Diabetes Obes Metab"},{"key":"key20190724090328_B29","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Research programs","author":"Wells","year":"2000","unstructured":"29. Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Research programs. Ottawa Health Research Institute. 2000.","journal-title":"Ottawa Health Research Institute"},{"issue":"19","key":"key20190724090328_B30","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","unstructured":"30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.","journal-title":"JAMA"},{"issue":"16","key":"key20190724090328_B31","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","unstructured":"31. Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.","journal-title":"Circulation"},{"issue":"11","key":"key20190724090328_B32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta\u2010analysis","volume":"21","author":"Higgins","year":"2002","unstructured":"32. Higgins J, Thompson SG. Quantifying heterogeneity in a meta\u2010analysis. Stat Med. 2002;21(11):1539-58.","journal-title":"Stat Med"},{"issue":"3","key":"key20190724090328_B33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","unstructured":"33. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.","journal-title":"Control Clin Trials"},{"key":"key20190724090328_B34","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies","volume":"22","author":"Mantel","year":"1959","unstructured":"34. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies. J Natl Cancer Inst. 1959;22:719-48.","journal-title":"J Natl Cancer Inst"},{"issue":"7109","key":"key20190724090328_B35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","unstructured":"35. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34.","journal-title":"BMJ"},{"issue":"4","key":"key20190724090328_B36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","unstructured":"36. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101.","journal-title":"Biometrics"},{"issue":"5","key":"key20190724090328_B37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1323","article-title":"Metabolically healthy obesity and development of chronic kidney disease: a cohort study","volume":"164","author":"Chang","year":"2016","unstructured":"37. Chang Y, Ryu S, Choi Y, Zhang Y, Cho J, Kwon MJ, et al. Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann Intern Med. 2016;164(5):305-12.","journal-title":"Ann Intern Med"},{"issue":"4","key":"key20190724090328_B38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ki.2015.183","article-title":"The risk of chronic kidney disease in a metabolically healthy obese population","volume":"88","author":"Jung","year":"2015","unstructured":"38. Jung CH, Lee MJ, Kang YM, Hwang JY, Kim EH, Park JY, et al. The risk of chronic kidney disease in a metabolically healthy obese population. Kidney Int. 2015;88(4):843-50.","journal-title":"Kidney Int"},{"issue":"7","key":"key20190724090328_B39","first-page":"1","article-title":"Effect of Different Obesity Phenotypes on Incidence of Chronic Kidney Disease in Tehranian Adults","volume":"35","author":"Mottaghi","year":"2015","unstructured":"39. Mottaghi A, Mirmiran P, Delshad H, Azizi F. Effect of Different Obesity Phenotypes on Incidence of Chronic Kidney Disease in Tehranian Adults. J Am Coll Nutr. 2015;35(7):1-10.","journal-title":"J Am Coll Nutr"},{"key":"key20190724090328_B40","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-015-0083-8","article-title":"Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort","volume":"16","author":"Cao","year":"2015","unstructured":"40. Cao X, Zhou J, Yuan H, Wu L, Chen Z. Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort. BMC Nephrol. 2015;16:85.","journal-title":"BMC Nephrol"},{"issue":"4","key":"key20190724090328_B41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2215\/CJN.08980914","article-title":"Metabolically healthy obesity and risk of incident CKD","volume":"10","author":"Hashimoto","year":"2015","unstructured":"41. Hashimoto Y, Tanaka M, Okada H, Senmaru T, Hamaguchi M, Asano M, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10(4):578-83.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"key20190724090328_B42","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10157-015-1083-5","article-title":"Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study","volume":"19","author":"Song","year":"2015","unstructured":"42. Song YM, Sung J, Lee K. Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study. Clin Exp Nephrol. 2015;19(5):887-94.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"key20190724090328_B43","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/oby.21768","article-title":"Metabolically healthy obesity and incident chronic kidney disease: The role of systemic inflammation in a prospective study","volume":"25","author":"Lin","year":"2017","unstructured":"43. Lin L, Peng K, Du R, Huang X, Lu J, Xu Y, et al. Metabolically healthy obesity and incident chronic kidney disease: The role of systemic inflammation in a prospective study. Obesity (Silver Spring). 2017;25(3):634-41.","journal-title":"Obesity (Silver Spring"},{"issue":"3","key":"key20190724090328_B44","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1210\/jc.2018-01321","article-title":"Natural History of Obesity Subphenotypes: Dynamic Changes Over Two Decades and Prognosis in the Framingham Heart Study","volume":"104","author":"Echouffo-Tcheugui","year":"2019","unstructured":"44. Echouffo-Tcheugui JB, Short MI, Xanthakis V, Field P, Sponholtz TR, Larson MG, et al. Natural History of Obesity Subphenotypes: Dynamic Changes Over Two Decades and Prognosis in the Framingham Heart Study. J Clin Endocrinol Metab. 2019;104(3):738-752.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20190724090328_B45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1262-3636(07)70156-8","article-title":"Can we identify metabolically healthy but obese individuals (MHO)?","volume":"30","author":"Karelis","year":"2004","unstructured":"45. Karelis A, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30(6):569-72.","journal-title":"Diabetes Metab"},{"issue":"5","key":"key20190724090328_B46","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.ijcard.2013.07.230","article-title":"Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies","volume":"168","author":"Fan","year":"2013","unstructured":"46. Fan J, Song Y, Chen Y, Hui R, Zhang W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;168(5):4761-8.","journal-title":"Int J Cardiol"},{"issue":"1","key":"key20190724090328_B47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semnephrol.2012.12.006","article-title":"Obesity and kidney disease: potential mechanisms","volume":"33","author":"Wickman","year":"2013","unstructured":"47. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013;33(1):14-22.","journal-title":"Semin Nephrol"},{"key":"key20190724090328_B48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2147\/DMSO.S46674","article-title":"Elevated body mass index as a risk factor for chronic kidney disease: current perspectives","volume":"7","author":"Garland","year":"2014","unstructured":"48. Garland JS. Elevated body mass index as a risk factor for chronic kidney disease: current perspectives. Diabetes Metab Syndr Obes. 2014;7:347-55.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"key20190724090328_B49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11255-011-9974-1","article-title":"The role of obesity in kidney disease: recent findings and potential mechanisms","volume":"43","author":"Kalaitzidis","year":"2011","unstructured":"49. Kalaitzidis RG, Siamopoulos KC. The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol. 2011;43(3):771-84.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"key20190724090328_B50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cen.12154","article-title":"Higher mortality in metabolically obese normal\u2010weight people than in metabolically healthy obese subjects in elderly Koreans","volume":"79","author":"Choi","year":"2013","unstructured":"50. Choi KM, Cho HJ, Choi HY, Yang SJ, Yoo HJ, Seo JA, et al. Higher mortality in metabolically obese normal\u2010weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol (Oxf). 2013;79(3):364-70.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key20190724090328_B51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11906-012-0245-z","article-title":"The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome","volume":"14","author":"Thethi","year":"2012","unstructured":"51. Thethi T, Kamiyama M, Kobori H. The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep. 2012;14(2):160-9.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"key20190724090328_B52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MNH.0b013e3283374c09","article-title":"Scope and mechanisms of obesity-related renal disease","volume":"19","author":"Hunley","year":"2010","unstructured":"52. Hunley TE, Ma LJ, Kon V. Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens. 2010;19(3):227-34.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"key20190724090328_B53","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/mp.2013.162","article-title":"Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies","volume":"19","author":"Jokela","year":"2014","unstructured":"53. Jokela M, Hamer M, Singh-Manoux A, Batty G, Kivim\u00e4ki M. Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies. Mol Psychiatry. 2014;19(8):910-4.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"key20190724090328_B54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3748\/wjg.v22.i2.681","article-title":"New obesity classification criteria as a tool for bariatric surgery indication","volume":"22","author":"De Lorenzo","year":"2016","unstructured":"54. De Lorenzo A, Soldati L, Sarlo F, Calvani M, Di Lorenzo N, Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol. 2016;22(2):681-703.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"key20190724090328_B55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ije\/dyl245","article-title":"Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis","volume":"36","author":"Sniderman","year":"2007","unstructured":"55. Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol. 2007;36(1):220-5.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"key20190724090328_B56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","unstructured":"56. Tchernof A, Despr\u00e9s JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359-404.","journal-title":"Physiol Rev"},{"issue":"4","key":"key20190724090328_B57","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pcad.2013.10.003","article-title":"The concept of normal weight obesity","volume":"56","author":"Oliveros","year":"2014","unstructured":"57. Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F. The concept of normal weight obesity. Prog Cardiovasc Dis. 2014;56(4):426-33.","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"key20190724090328_B58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ajcn\/85.1.40","article-title":"Normal-weight obese syndrome: early inflammation?","volume":"85","author":"De Lorenzo","year":"2007","unstructured":"58. De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal-weight obese syndrome: early inflammation? Am J Clin Nutr. 2007;85(1):40-5.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"key20190724090328_B59","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis","volume":"159","author":"Kramer","year":"2013","unstructured":"59. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758-69.","journal-title":"Ann Intern Med"},{"issue":"9","key":"key20190724090328_B60","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/2047487315623884","article-title":"Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis","volume":"23","author":"Eckel","year":"2016","unstructured":"60. Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):956-66.","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"key20190724090328_B61","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2337\/dc15-1218","article-title":"Definitions of metabolic health and risk of future type 2 diabetes in BMI categories: a systematic review and network meta-analysis","volume":"38","author":"Lotta","year":"2015","unstructured":"61. Lotta LA, Abbasi A, Sharp SJ, Sahlqvist AS, Waterworth D, Brosnan JM, et al. Definitions of metabolic health and risk of future type 2 diabetes in BMI categories: a systematic review and network meta-analysis. Diabetes Care. 2015;38(11):2177-87.","journal-title":"Diabetes Care"},{"issue":"1","key":"key20190724090328_B62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2014.09.077","article-title":"The natural course of healthy obesity over 20 years","volume":"65","author":"Bell","year":"2015","unstructured":"62. Bell JA, Hamer M, Sabia S, Singh-Manoux A, Batty GD, Kivimaki M. The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015;65(1):101-2.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20190724090328_B63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/oby.20248","article-title":"Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study","volume":"21","author":"Bradshaw","year":"2013","unstructured":"63. Bradshaw PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study. Obesity (Silver Spring). 2013;21(1):203-9.","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"key20190724090328_B64","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/aje\/kwv178","article-title":"Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype","volume":"182","author":"Bradshaw","year":"2015","unstructured":"64. Bradshaw PT, Stevens J. Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype. Am J Epidemiol. 2015;182(9):742-4.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"key20190724090328_B65","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/ijo.2015.56","article-title":"Three-year weight change and cardiometabolic risk factors in obese and normal weight adults who are metabolically healthy: The atherosclerosis risk in communities study","volume":"39","author":"Cui","year":"2015","unstructured":"65. Cui Z, Truesdale KP, Bradshaw PT, Cai J, Stevens J. Three-year weight change and cardiometabolic risk factors in obese and normal weight adults who are metabolically healthy: The atherosclerosis risk in communities study. Int J Obes (Lond). 2015;39(8):1203-8.","journal-title":"Int J Obes (Lond)"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T09:19:17Z","timestamp":1563959957000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972019005006103&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":65,"alternative-id":["10.20945\/2359-3997000000149"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000149","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]}}}